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RESEARCH ARTICLE

Dysphagia and disrupted cranial nerve development in a mouse
model of DiGeorge (22q11) deletion syndrome

ABSTRACT
We assessed feeding-related developmental anomalies in the LgDel
mouse model of chromosome 22q11 deletion syndrome (22q11DS),
a common developmental disorder that frequently includes perinatal
dysphagia – debilitating feeding, swallowing and nutrition difficulties
from birth onward – within its phenotypic spectrum. LgDel pups gain
significantly less weight during the first postnatal weeks, and have
several signs of respiratory infections due to food aspiration. Most
22q11 genes are expressed in anlagen of craniofacial and brainstem
regions critical for feeding and swallowing, and diminished expression
in LgDel embryos apparently compromises development of these
regions. Palate and jaw anomalies indicate divergent oro-facial
morphogenesis. Altered expression and patterning of hindbrain
transcriptional regulators, especially those related to retinoic acid
(RA) signaling, prefigures these disruptions. Subsequently, gene
expression, axon growth and sensory ganglion formation in the
trigeminal (V), glossopharyngeal (IX) or vagus (X) cranial nerves
(CNs) that innervate targets essential for feeding, swallowing and
digestion are disrupted. Posterior CN IX and X ganglia anomalies
primarily reflect diminished dosage of the 22q11DS candidate gene
Tbx1. Genetic modification of RA signaling in LgDel embryos rescues
the anterior CN V phenotype and returns expression levels or pattern
of RA-sensitive genes to those in wild-type embryos. Thus,
diminished 22q11 gene dosage, including but not limited to Tbx1,
disrupts oro-facial and CN development by modifying RA-modulated
anterior-posterior hindbrain differentiation. These disruptions likely
contribute to dysphagia in infants and young children with 22q11DS.
KEY WORDS: DiGeorge/22q11 deletion syndrome, Cranial nerve
development, Dysphagia, Hindbrain patterning

INTRODUCTION

Dysphagia – disrupted feeding, swallowing and nutrition – is a
serious complication of several developmental disorders, including
22q11 deletion syndrome (22q11DS) (Christensen, 1989; Ang et al.,
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1999; Eicher et al., 2000; Schwarz et al., 2001; Rommel et al.,
2008). Perinatal dysphagia is especially challenging to manage
(Schwarz et al., 2001; Kelly, 2006; Lefton-Greif, 2008), and
frequently results in aspiration-based infection and other
complications (Hopkin et al., 2000; Trinick et al., 2012).
Nevertheless, there is little appreciation of developmental
pathogenic mechanisms that underlie dysphagia and, to our
knowledge, no genetic models with early disruption of feeding and
swallowing to facilitate detailed analysis. Thus, we investigated
whether the LgDel mouse, a genomically accurate 22q11DS model
that carries a heterozygous deletion of 28 contiguous genes on
mouse chromosome 16 parallel to the minimal critical deleted region
in 22q11DS patients (Merscher et al., 2001), provides a robust
animal model for key features of dysphagia in 22q11DS and perhaps
other neurodevelopmental disorders.
Dysphagia probably contributes to diminished weight gain
(Tarquinio et al., 2012), increased naso-sinus and lung infections,
and gastrointestinal reflux in 22q11DS infants and children. Some
difficulties might reflect cardiovascular or immunological anomalies
(Jawad et al., 2001); however, nasopharyngeal and airway
dysmorphology (Huang and Shapiro, 2000; Marom et al., 2012) as
well as altered oro-facial sensory and/or motor control (Zori et al.,
1998) probably initiates or exacerbates aspiration or reflux that leads
to discomfort and infection (Lundy et al., 1999; Rommel et al.,
2008; Lima et al., 2010; Trinick et al., 2012). The pathogenesis of
these complications remains unknown, presumably because
developmental causes cannot be easily studied in 22q11DS patients.
Thus, we assessed key signs of dysphagia in the LgDel mouse to
determine whether feeding and swallowing is compromised
perinatally, and whether developmental correlates of these changes
could be studied in this animal model.
Optimal oro-facial morphogenesis is crucial for normal feeding
and swallowing (Reilly et al., 1999; Barrow et al., 2000). Oro-facial
development depends critically on appropriate levels and patterns of
key regulatory genes first in the embryonic hindbrain and then in
craniofacial primordia derived from hindbrain neural crest.
Subsequent innervation by the trigeminal (V), facial (VII),
glossopharyngeal (IX), vagus (X) and hypoglossal (XII) nerves is
crucial for effective oro-facial sensory and/or motor control. There
is currently no evaluation of disrupted oro-facial development,
hindbrain gene expression or cranial nerve (CN) differentiation in
the LgDel 22q11DS mouse model. Accordingly, we evaluated palate
and jaw morphogenesis, expression of genes involved in hindbrain
regionalization, CN differentiation and axon guidance, and identified
phenotypes in CNs critical for feeding and swallowing in developing
LgDel mice. In parallel, we investigated whether phenotypic
changes reflect broad 22q11 deletion or that of the 22q11DS
candidate gene Tbx1.
Weight gain, respiratory health and craniofacial morphogenesis
are altered in LgDel mice. Gene expression levels and patterns
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TRANSLATIONAL IMPACT
Clinical issue
Pediatric dysphagia – compromised food ingestion, chewing and
swallowing – is a major complication for children with developmental
disorders. Indeed, these difficulties are seen in up to 80% of children with
developmental disorders. The consequences of pediatric dysphagia can
be devastating and include diminished food intake, decreased weight
gain, inadequate nutrition, choking, food aspiration, and subsequent
naso-sinus, inner ear and respiratory infections including pneumonia.
Despite these consequences, and their burden for the health and growth
of children with developmental disorders, little is known about the
etiology of pediatric dysphagia, in part because its pathology arises
during fetal development and thus cannot be studied in patients, and in
part because there are no animal models that encompass the key signs
of the disease.
Results
In this study, the authors report that dysphagic symptoms, including
diminished weight gain, nasopharyngeal milk aspiration, and naso-sinus,
inner ear and lung infections, develop during early postnatal life in the
LgDel mouse model of DiGeorge (22q11.2) deletion syndrome
(22q11DS), a common developmental disorder with a substantial
incidence of pediatric dysphagia. They show that these symptoms are
prefigured by altered expression and patterning of genes in embryonic
domains that generate the oro-pharyngeal structures and the cranial
nerves critical for feeding and swallowing, and that cranial nerve
development is disrupted in the LgDel mouse. These disruptions reflect
contiguous gene effects within the 22q11-deleted region. Altered
trigeminal nerve development is mediated by retinoic acid (RA)-sensitive
genes, they report, and is rescued by diminished RA signaling in LgDel
mice. Finally, the authors demonstrate that altered glossopharyngeal and
vagal nerve development reflects Tbx1 haploinsufficiency, which is also
implicated in the cardiovascular phenotypes of 22q11DS.

change in the developing hindbrain and trigeminal ganglia. In
parallel, hindbrain and CN differentiation is disrupted. Anterior CN
phenotypes reflect broad 22q11 gene deletion and altered hindbrain
RA signaling; posterior phenotypes reflect haploinsufficiency of the
22q11DS candidate gene Tbx1 (Scambler, 2010). Thus, diminished
22q11 gene dosage in the LgDel model of 22q11DS, including – but
not limited to – Tbx1, disrupts oro-facial development and function.
Parallel changes in 22q11DS patients likely contribute to clinically
significant feeding and swallowing difficulties during early life.
RESULTS
Evidence of altered feeding and swallowing in LgDel mice

From birth onward, 22q11DS patients fail to gain weight at the same
rates as typically developing children (Tarquinio et al., 2012), have
difficulties ingesting and swallowing, and a high incidence of
aspiration-related naso-sinus, respiratory and inner ear infections
(Eicher et al., 2000; Hopkin et al., 2000; Jawad et al., 2001). To
determine whether LgDel pups exhibit similar defining features of
pediatric dysphagia, we first investigated whether they weigh the
246

Fig. 1. Growth curves for LgDel and WT littermate males and females
from P1 through P30. (A) Growth curves for male LgDel and WT littermates,
weighed daily from P1 through P7, then weekly from P7 through P28 (x-axis).
(B) Growth curve for female LgDel and WT littermates. (C) Normalized mean
weights for male and female LgDel and WT littermates. The boxes represent
standard errors of each mean (s.e.m.), and bars reflect standard deviations
for each data point. Growth curves were compared by ANOVA (A,B), and
mean normalized values compared using Mann-Whitney analysis (C).

same as wild-type (WT) counterparts at birth, but fail to gain weight
similar to WT littermates over the first postnatal month. LgDel pups
of both sexes – analyzed separately – weigh the same as WT
littermates at birth; however, LgDel weight gain slows from
postnatal day 4 (P4) through P30 (P≤0.0004, two-way ANOVA; n=9
LgDel, 9 WT males; P≤0.0001, 8 LgDel, 14 WT females). To
confirm the significance of these differences, independent of sex, we
normalized LgDel weights to those of WT male or female
counterparts (Fig. 1C). LgDel pups are first significantly lighter at
P4 (although the P5 difference does not reach significance) through
P30 (Mann-Whitney, P≤0.001; Fig. 1C). By adolescence, LgDel
weight is 80% (males) to 85% (females) of their WT counterparts,
similar to the 15% decrease in body weight of adolescent 22q11DS
patients versus typically developing controls (Tarquinio et al., 2012).
We next investigated whether milk was aspirated into respiratory
passages or whether there were signs of aspiration-related irritation or
infection in LgDel pups or WT littermates. In the nasal sinuses,
Eustachian tubes and lungs of LgDel but not WT littermate P7 pups,
we found protein-rich aggregates that included murine milk protein,
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Implications and future directions
These findings identify an animal model for pediatric dysphagia that will
permit the detailed study of the craniofacial and nervous system
developmental disruptions that cause the disorder, and of the peripheral
and central nervous system circuitry that is compromised. The authors’
genetic rescue experiments provide a foundation for potential
amelioration of pathogenesis in the animal model, and eventually in
patients. The LgDel mouse can also be used as a resource to help
identify genes and environmental exposures that exacerbate pediatric
dysphagia. Finally, the LgDel mouse provides a tool for devising new
ways to predict which patients will develop the challenging clinical
complications of pediatric dysphagia and for devising therapies to
ameliorate the symptoms of the condition.
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bacteria, red blood cells, macrophages and neutrophils (Fig. 2;
P≤0.05, chi square; n=LgDel: 4/5, WT: 1/4). In the nasal sinuses, there
were large accumulations of murine milk protein, frequently infiltrated
with CD-64-positive neutrophils (Fig. 2, top right). In the Eustachian
tubes, we found mucus accumulations and an apparent increase in
mucus-producing goblet cells (Fig. 2, middle row), which are signs of
ear infection (Cayé-Thomasen and Tos, 2003). In the lungs, milk
protein aggregates accompanied red blood cells and macrophages
(Fig. 2, bottom row and inset), also signs of infection. Thus, increased
milk aspiration, accumulation of red blood cells, mucus-producing
cells and immune cells, together with diminished weight gain, show
that LgDel pups have many features that parallel clinical signs of
dysphagia in infants and children with 22q11DS.
Craniofacial changes in LgDel mice

22q11DS patients have palate and jaw anomalies (Fukui et al., 2000;
Emanuel et al., 2001; Ousley et al., 2007) that contribute to feeding
and swallowing difficulties. It is not clear, however, whether 22q11
genes act in palate or jaw primordia, and whether diminished dosage
alters morphogenesis in LgDel mice. We investigated whether a
substantial number of 22q11 genes are expressed in embryonic
structures that contribute to the palate, upper jaw and lower jaw
(Fig. 3, top). We screened 21 candidates from the deleted region
based on previous assessments of expression in the embryo and
developing brain (Maynard et al., 2003; Meechan et al., 2009;
Maynard et al., 2013). Using quantitative RT-PCR analysis (qPCR)
in microdissected samples of maxillary process/branchial arch
(BA1A; Fig. 3, top) or a combined mandibular/hyoid sample
(BA1B/BA2; Fig. 3, middle top) consisting of the mandibular
process (BA1B) and the hyoid process (BA2), we found 16/28
(BA1A) and 19/28 (BA1B/BA2) 22q11 genes expressed in the
craniofacial primordia. Thus, local diminished dosage of 22q11
genes might compromise craniofacial morphogenesis.

The consequences of diminished 22q11 gene dosage in 22q11DS
patients include, with variable penetrance, compromised palatal
elevation that results in velopharyngeal insufficiency (Ruda et al.,
2012). We therefore examined the developing palate in LgDel mice
for signs of dysmorphogenesis, including failed elevation of the
palatal shelves during fetal development as well as thinned palatal
cartilage in the adult. In mid-gestation (E13.5) LgDel embryos, we
found evidence of failed palatal shelf elevation (Fig. 3, middle),
albeit at fairly low penetrance (2/7 LgDel versus 0/7 WT), parallel
to low penetrance of similar phenotypes in 22q11DS patients
(Kobrynski and Sullivan, 2007). We found no clear evidence of
palatal cartilage thinning or other signs of palatal dysmorphogenesis
in P7 LgDel pups (not shown), perhaps because severely affected
pups are lost at or soon after birth. 22q11DS patients also have
mandibular anomalies, including retrognathia (Friedman et al.,
2011). In P30 LgDel mice, mandible size and shape are altered.
Distances between the ventral condylar process, points on the
masseteric ridge and the alveolus of the incisor (Fig. 3, bottom left)
are decreased relative to WT (Fig. 3, bottom right; P≤0.005, t-test;
n=LgDel 47, WT 46 hemi-mandibles). Thus, low-penetrance palate
anomalies and mature mandible dysmorphology indicate that orofacial development related to feeding and swallowing is altered in
LgDel mice.
Altered hindbrain morphogenesis, gene expression and
patterning in LgDel embryos

Optimal oro-facial development depends upon the emergence of
rhomobomeres – metameric units that prefigure anterior-posterior
(A-P) CN differentiation – and associated gene expression. To assess
whether aberrant rhombomere morphogenesis and patterning
prefigures LgDel dysphagia-related changes, we determined whether
22q11 genes could influence the developing hindbrain based upon
local expression. In micro-dissected E9.5 hindbrain samples
247
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Fig. 2. P7 LgDel mice show signs of
dysphagia, including nasal, ear and
lung milk-aspiration inflammation or
infection. Top row: aspiration-related
protein aggregates adjacent to the
turbinates of the olfactory epithelium (oe)
in P7 WT and LgDel pups. The protein
aggregates (asterisks), seen only in LgDel
pups, contain murine milk protein (far
right; fluorescent Nissl stain, green;
immunolabel for milk protein, red) as well
as neutrophils (anti-CD64, blue). Middle
row: mucus aggregates are seen in the
Eustachian tubes of LgDel P7 pups,
accompanied by an apparent increase in
the frequency of mucus-producing goblet
cells (bracket/arrows, far right panel; PAS
stain) at the boundary of the pharynx
(Resp.; arrows) and Eustachian (Eust.;
bracket) tube epithelium. Bottom row:
LgDel lungs have more frequent evidence
of inflammation and/or infection, including
red blood cell aggregates (arrows, middle
insert), macrophages (arrowheads, and
inset, middle) and infiltration of murine
milk protein (far right panel; green,
fluorescent Nissl stain; red, milk protein
immunolabel).

Fig. 3. Altered palate and jaw morphology in LgDel mice. Top:
quantitative real time PCR (qPCR) analysis of a subset of 22q11 deleted
genes in microdissected rudiments of key orofacial structures for feeding and
swallowing: BA1A, which includes the maxilla, which gives rise to the upper
jaw, mouth structures and some muscles of mastication, and BA1B/BA2,
which includes the mandible and hyoid, which gives rise to the lower jaw and
some pharyngeal structures. These 22q11 genes were chosen based upon
expression above a threshold level – 0.01% of Gapdh expression measured
in the same sample – in a previous analysis of developing E10.5 embryos or
the brain from E12.5 onward (Maynard et al., 2003). Expression was
quantified. Middle: sections through the anterior and posterior palatal region
in E13.5 WT and LgDel embryos demonstrating failure of palatal elevation in
the LgDel (compare arrows). The palate has not fused in either the WT or
LgDel at this age. WT palatal shelves are more frequently elevated (left
arrows) than those in the LgDel (right arrows). Bottom left: lateral view of the
mandibular process from a WT mouse, with reference points for
measurements indicated as numbers 1-6. Bottom right: morphometry of
point-to-point distances between cardinal locations shown at left indicates
that mandibular growth is diminished in LgDel versus WT littermate mice
(*P≤0.5; **P≤0.01, t-test; n=48 LgDel, 46 WT).
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(rhombomere r1 to r8), we detected substantial expression of 17 out
of 21 relevant 22q11 genes (Fig. 4, top). Four genes, including Tbx1,
that are associated with cardiovascular and other 22q11DS
phenotypes (Scambler, 2010) fell below confident detection levels
(≤0.01% of Gapdh in the same sample). Thus, local diminished
expression of a substantial subset of 22q11 genes could alter
hindbrain morphogenesis, differentiation and patterning.
We assessed hindbrain differentiation by evaluating regions
anterior and posterior to cardinal expression domains, defined by
dual Hoxb1 and En1 immunolabeling. The E9.5 LgDel anterior
hindbrain (Fig. 4, arrows, top middle) appeared compressed, and
dorsal margins of the neuroepithelium appeared deformed (Fig. 4,
arrowheads, top middle). Thus, anterior – but not posterior –
rhombomeres seem relatively smaller and dysmorphic in the LgDel
versus WT. We next investigated whether expression of a subset of
retinoic acid (RA) co-factors and Hox genes, which, when
dysregulated, disrupt A-P rhombomere identity (Marshall et al.,
1992) (reviewed by Glover et al., 2006), was altered using qPCR in
E9.5 microdissected hindbrains (r1-r8). Rarα and Rarβ, RA
receptors found in posterior rhombomeres, increase by 34 and 47%,
respectively (P≤0.04 and 0.02, Mann-Whitney, n=12 LgDel, 12
WT). Cyp26b1, an RA-regulated RA catabolic enzyme expressed at
distinct levels in r6 to r2 (Abu-Abed et al., 1998; Reijntjes et al.,
2003; Okano et al., 2012), is increased by 160% (P≤0.009), and
Cyp26c1 (r2) (Tahayato et al., 2003) is increased by 54% (P≤0.004).
Hoxa1 (r4-r8) increased by 74% (P≤0.001), and Hoxa2 (r2-4 and
posterior) by 38% (P≤0.04). The Shh transcriptional effector Gli1
(r1) increases by 30% (P≤0.04). In contrast, Shh expression (no AP distinction) was unchanged. We observed no significant
differences for any of the RA-regulated genes in E9.5 LgDel versus
WT cervical/thoracic spinal cord (data not shown); the changes we
detect are limited to anterior or posterior hindbrain domains.
Individual hindbrain expression levels varied; nevertheless,
minimum and maximum levels were always higher in LgDel versus
WT (Fig. 4, middle bottom right). Apparently, 22q11 deletion
modifies gene expression levels that distinguish anterior or posterior
rhombomeres, including several RA-regulated genes.
These expression level changes suggest that anterior rhombomere
patterning is disrupted, potentially via posteriorizing influences of
RA. Thus, we evaluated the expression pattern of Cyp26b1, which
is known to be RA regulated (see above), has been implicated in
determining RA-responsiveness of hindbrain cells (Hernandez et al.,
2007) and whose altered expression – especially in the context of
null mutations of the 22q11 candidate gene Tbx1 (see below) – can
compromise craniofacial development (Roberts et al., 2006; Okano
et al., 2008; Okano et al., 2012). Bounded patterns and gradients of
Cyp26b1 distinguish posterior from anterior rhombomeres. In the
WT hindbrain, there is intense expression in r5/6, progressively
diminished expression in r3/4 and barely detectable expression in r2
(Fig. 4, bottom left panel). In the LgDel hindbrain, we found
increased Cyp26b1 signal in r6 through r3, and enhanced expression
in r2, substantially above levels seen in any of the WT embryos
(Fig. 4, bottom right panel; seen in 8/11 LgDel embryos versus 0/10
WT). These pattern changes, which parallel Cyp26b1 level changes,
are consistent with anomalous acquisition of posterior character in
LgDel anterior rhombomeres, perhaps due to aberrant RA signaling.
Disrupted CN and CNg development in LgDel embryos

Changes in rhombomere differentiation, gene expression and
patterning together with postnatal anomalies in growth, feeding and
craniofacial morphogenesis in LgDel mice suggest that CN
development, which is essential for normal oro-facial function
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(reviewed by Trainor and Krumlauf, 2000; Cordes, 2001), might be
altered. To evaluate potential sensitivity of developing CNs to 22q11
gene dosage, we first assessed 22q11 gene expression in

microdissected samples of CN ganglion (CNg) V from LgDel and
WT embryos. 16 out of 21 22q11 genes, nearly identical to those in
the hindbrain (see Fig. 4), are expressed in CNg V (Fig. 5, top
panel). This substantial local CN expression of 22q11 genes, as well
as E9.5 hindbrain anomalies, suggests that CN differentiation might
be altered in the LgDel mouse at E10.5. We immunolabeled CN
axons and assessed their position and growth in whole E10.5
embryos. CNs and CNgs (CN V and VII) associated with the
anterior hindbrain appeared compressed, consistent with
morphogenetic, gene expression and patterning changes from r4 to
r1 at E9.5 (see Fig. 4). The distance between CNg V and CNg VII,
whose development depends upon appropriate r1 to r4 patterning
(reviewed by Cordes, 2001), was diminished (Fig. 5, middle left
panel). Similarly, the position of CN V and CN VII motor roots was
altered and they were less branched (Fig. 5, middle left panel,
asterisks). Finally, CNg X and CNg IX were compressed, and their
motor roots altered (Fig. 5, middle left panel, arrows).
Based upon these changes in CN differentiation, we evaluated
expression levels of adhesion molecules and transcriptional
regulators in CNg V to determine whether selected regulators of CN
development diverge in WT and LgDel embryos. We assessed
chemoattractant and chemorepulsive signaling receptors, cell surface
adhesion ligands, and neurotrophin receptors. Robo2, one of the
receptors for the Slit family of secreted adhesion molecules and
which has previously been associated with trigeminal gangliogenesis
(Shiau et al., 2008), as well as the L1Cam adhesion molecule that
influences axon fasciculation and guidance, are increased in the
E10.5 LgDel CNg V (Fig. 5, bottom left panel). The Robo2 increase
was significant (P≤0.05, t-test; n=8 LgDel, 12 WT), whereas that for
L1Cam showed a trend (P≤0.06, t-test). Thus, diminished dosage of
22q11 genes modestly alters gene expression levels for a subset of
adhesion signaling molecules in CNg V.
These changes indicate potential divergence in LgDel versus WT
CN differentiation, perhaps distinguishing anterior versus posterior
CNs. We identified three distinct features of CN morphology that
were consistently altered in a sample of 24 LgDel E10.5 embryos
compared with 23 WT controls (Fig. 5, bottom right panels):
diminished complexity and apparent length of the maxillary branch
of the trigeminal nerve (CN V; Fig. 5, first row, bottom right);
249
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Fig. 4. Altered gene expression, morphogenesis and patterning in the
LgDel E9.5 anterior hindbrain. Top: qPCR analysis of 22q11 gene
expression above threshold levels in the microdissected E9.5 hindbrain (r1 to
r8). 16 out of 21 candidates are expressed above threshold. Note that Tbx1,
a key 22q11 candidate gene for cardiovascular phenotypes, is not detected
in the E9.5 hindbrain. Middle top: apparent pattern changes and
dysmorphogenesis in the E9.5 anterior hindbrain. The distance between r4
and r1/2 in the WT, defined by Hoxb1 and En1 immunolabeling (left) is
greater than that in the LgDel (right; compare white bars and arrow), and the
dorsal margins of the neuroepithelium appear deformed (compare
arrowheads). Middle bottom left: summary of qPCR analysis of expression of
several genes that distinguish posterior (top) from anterior (bottom)
rhombomeres in the E9.5 microdissected hindbrain (r1 to r8). Middle bottom
right: scatterplots of expression levels in individual hindbrain samples of four
RA-regulated genes – two found in posterior rhombomeres (Rarα, Rarβ), two
with distinctly patterned expression in both anterior and posterior
rhombomeres (Cyp26b1, Hoxa2). Bottom: (left) in the WT E9.5 hindbrain,
Cyp26b1 is expressed at high levels in r5/6, lower levels in r3/4 and is barely
detectable in r2. (Right) In the LgDel E9.5 hindbrain from an embryo
hybridized concomitantly with the WT at left, Cyp26b1 is increased in r5/6,
significantly stronger in r3/4 and is now clearly detectable in r2 (compare
arrows, left and right). In addition, r5/6 boundaries have expanded in the
LgDel (compare left brackets), and r2 to r4 have contracted (compare right
brackets).
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Fig. 5. CN development is altered in E10.5
LgDel embryos. Top: 16 out of 21 22q11 deleted
genes are expressed above threshold in CNg V,
based upon qPCR analysis of microdissected WT
E10.5 CNg V samples. Middle left: a
representative E10.5 WT embryo labeled
immunocytochemically for neurofilament protein
shows the E10.5 WT hindbrain and associated
cranial nerves (CN) and ganglia (CNg). In the
LgDel (right), CNg V and VII appear more closely
spaced (arrow), their motor roots less
differentiated (asterisks), and, parallel to E9.5, the
anterior hindbrain appears compressed. In
addition, CNg IX and X appear fused in the LgDel
(arrows). Bottom left panel: expression changes
in LgDel CNg V determined by qPCR of
microdissected ganglia from LgDel versus WT
E10.5 embryos. Robo2 (black bar) is significantly
increased (P≤0.03) and L1cam (gray bar) shows
a significant trend toward increased expression
(P≤0.06). Middle right: (left) a lateral view of
typical WT axon trajectories and fasciculation as
well as the position of cranial sensory ganglia for
a subset of CNs. (Right) CN development is
altered in an E10.5 LgDel embryo (asterisks). CN
V appears sparse and de-fasciculated, the normal
bifurcation of CN VII is not evident, and the
ganglia of CN IX and X are fused. Middle bottom
right: specific CN phenotypes in LgDel embryos.
These examples, from additional WT and LgDel
embryos, are representative of the features
scored for quantitative phenotypic analysis. First
row: the ophthalmic (op, arrow), maxillary (mx,
bracket) and mandibular (md, arrows) branches
of CN V appear dysmorphic in LgDel E10.5
embryos. Second row: the bifurcation (arrows) of
CN VII that prefigures its division into multiple
dorsal and ventral branches, including the chorda
tympani, is frequently not evident in LgDel
embryos. Third row: the sensory ganglia of CN
IX/X and their immediate distal branches are
frequently fused in LgDel embryos (compare
arrows in left and right panels).
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(Fig. 6, bottom; P≤0.002). Thus, diminished 22q11 gene dosage
results in significant CN developmental phenotypes.
Posterior versus anterior CN phenotypes depend upon Tbx1
dosage

CNg IX and X fusions similar to those in LgDel embryos have been
reported in Tbx1−/− mutants (Vitelli et al., 2002), and might reflect
altered peripheral neural crest migration (Calmont et al., 2009). We
did not see anterior hindbrain compression or aberrant spacing of
CN V and VII in E10.5 Tbx1+/− embryos as in the LgDel (Fig. 7, far
left panel). We did not find the LgDel CN V phenotype or
substantial disruption of CN VII in 13 Tbx1+/− versus 11 WT
littermates (26 and 22 individual nerves/ganglia analyzed,
respectively, for each phenotype). We did find a significantly higher
frequency of CN IX/X ganglia fusion in Tbx1+/− versus WT embryos
(Fig. 7; P≤0.05) that approximates that seen in LgDel (Tbx1+/−: 62%
versus LgDel: 68%). Despite this similarity, Tbx1+/− pups do not
display the P7 weight difference seen in LgDel counterparts
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absence of bifurcation of the facial nerve within BA2 (CN VII;
Fig. 5, second row, bottom right panel); and anomalous axon
fascicles between, or actual fusion of, the glossopharyngeal and
vagus sensory ganglia and nerve (CN IX and X; Fig. 5, third row,
bottom right). We also examined the hypoglossal nerve (CN XII) but
found variability incompatible with consistent scoring. CN V, VII,
IX and X anomalies were seen occasionally in WT embryos;
however, the severity and frequency was substantially increased in
LgDel embryos. When each phenotype was scored blind by four
independent observers, we found a significant increase in LgDel CN
V and CN IX/X phenotypes (Fig. 6, top). CN V anomalies occurred
in a higher percentage of LgDel (42%) versus WT (16%, P<0.005;
Fisher’s exact test) embryos. CN VII branching failure also occurred
at a higher frequency in the LgDel (28%) versus WT (18%) mice;
however, this difference did not reach significance (P≤0.1). CN
IX/X fusion was the most frequent and statistically robust phenotype
(LgDel: 68%, WT: 31%, P≤0.0005). Finally, multiple phenotypes
(≥2) in a single embryo were significantly more frequent in LgDel
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Fig. 6. Statistically significant changes in phenotypic
frequency in developing CN V, IX and X in LgDel versus
WT embryos. Top panels: histograms showing the proportion
of WT (green) and LgDel (red) embryos with each of the three
phenotypes scored (CN V, VII and IX/X). Statistical
significance determined using Fisher’s exact analysis. The
CN V and IX/X phenotypes occur at significantly greater
frequency than in the WT; the CN VII phenotype does not.
Lower panels: frequency of single or multiple CN phenotypes
in WT and LgDel embryos. Overall phenotypic frequency is
substantially increased in LgDel mice, as is the number of
individual embryos showing multiple (two or three) CN
phenotypes.

Diminished RA signaling rescues anterior CN phenotypes in
LgDel embryos

Increased expression or expanded pattern of RA-regulated genes
(reviewed by Glover et al., 2006) suggest disruptions of A-P
patterning via enhanced RA signaling in the LgDel hindbrain. The
distinction between CN V and CN IX/X phenotypes in LgDel versus
Tbx1+/− mice also suggests potentially separable mechanisms for

anterior versus posterior CN disruption in the context of 22q11
deletion. Thus, we investigated whether genetic manipulation of RA
signaling due to heterozygous mutation of Raldh2, which diminishes
RA signaling in whole E10.5 embryos by 20% (Maynard et al.,
2013), modifies LgDel anterior versus posterior CN phenotypes. In
LgDel:Raldh2+/− compound embryos, the CN V phenotype was
consistently rescued (Fig. 8, top). In blind scoring of 12 CN V from
6 compound embryos, all were identified as non-phenotypic by four
independent observers (Fig. 8, middle). This phenotypic frequency
in LgDel:Raldh2+/− was significantly different from that in LgDel (0
versus 42%; P≤0.004; Fisher’s exact test). In contrast, the CN IX
and X phenotypic frequency was not significantly altered in
LgDel:Raldh2+/− embryos (87.5% LgDel:Raldh2+/−; 68% LgDel;
P≤0.3; Fisher’s exact test). Apparently, diminished Raldh2 activity
rescues anterior (CN V) but not posterior (CN IX/X) LgDel CN
phenotypes.
We next investigated whether this apparent anterior LgDel rescue
by Raldh2+/− returns LgDel expression levels of RA-regulated
signaling and transcription factors (see Fig. 4) toward those in WT
by qPCR in microdissected hindbrain samples (r8 to r1) from E9.5
WT, Raldh2+/−, LgDel and LgDel:Raldh2+/− embryos. Levels of all
but one of these genes (Hoxa1) were statistically indistinguishable

Fig. 7. Heterozygous Tbx1 mutation yields a CN IX/X phenotype parallel to that in E10.5 LgDel embryos. Left: the ganglia of CN IX and CN X are more
frequently connected by axon fascicles or fused (arrows) in E10.5 Tbx1+/− embryos than WT littermates. Middle left: quantitative analysis of CN phenotypes
shows a statistically significant CN IX/X phenotype with the same frequency in Tbx1+/− embryos as in LgDel embryos. Middle right: qPCR measurement of
gene expression in the CN V ganglion of E10.5 Tbx1+/− embryos, normalized to WT littermate control levels. Robo2 (black bar), which increases significantly in
the LgDel (see Fig. 5), decreases significantly in the Tbx1+/− CN V ganglion (asterisk). Right: Cyp26b1, which, in WT, is expressed at high levels in r5/6, lower
levels in r3/4 and barely detectable in r2, has a similar pattern of expression in r6 through r2 in Tbx1+/− embryos. There is no noticeable expansion of r5/6
(compare brackets left) or compression of r2 to r4 (compare brackets right).
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(Tbx1+/−: 4.11 g, n=7; WT littermates: 4.16 g, n=11; P=0.89).
Expression of L1Cam, modestly increased in LgDel CNg V (with a
significant trend; see Fig. 5), did not differ in Tbx1+/− versus WT;
however, Robo2 was significantly reduced (34%; P<0.05; Fig. 7),
opposite to the 36% increase in LgDel (Fig. 4). Finally, there was no
substantial expression intensity difference or anterior expansion of
Cyp26b1 in E9.5 Tbx1+/− vs WT littermate embryos hybridized
concurrently (7 Tbx1+/−; 3 WT; Fig. 7, far right). Thus, posterior CN
IX/X phenotypes in LgDel embryos reflect diminished Tbx1 dosage
– one of a small number of 22q11 genes not expressed in the
developing hindbrain – whereas those associated with anterior CN
V phenotypes are associated with diminished expression of
additional 22q11 genes and local changes of gene expression levels
or patterns, especially in the anterior hindbrain.
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Fig. 8. Heterozygous inactivation of Raldh2 rescues CN V, but not CN IX/X, phenotypes in LgDel embryos. Top left: (first row) comparison of CN V
differentiation in E10.5 Raldh2+/−, which resembles the WT (see Fig. 5), Raldh2+/−:LgDel, which also resembles the WT, and LgDel, which shows clear
disruption of fasciculation and differentiation of all major branches of CN V. The ophthalmic (op, arrow), maxillary (mx, bracket) and mandibular (md, arrows)
branches of CN V are shown. (Second row) Comparison of CN IX/X differentiation in E10.5 Raldh2+/−, Raldh2+/−:LgDel and LgDel embryos. CNs in Raldh2+/−
embryos resemble the WT, whereas Raldh2+/−:LgDel and LgDel have similar ganglion fusions (arrows) and disrupted axon trajectories. Top right: frequency of
phenotypes in 12 individual CN V and CN IX/X from six E10.5 Raldh2+/−:LgDel, or from six LgDel embryos. Statistical comparisons made using Fisher’s exact
analysis. Middle: A-P rhombomere selective genes, many of which are RA regulated (see Fig. 4), return to WT levels in E9.5 LgDel:Raldh2+/− hindbrains, based
upon qPCR analysis of microdissected hindbrain samples from n=8 Raldh2+/−; 7 LgDel:Raldh2+/−; 13 WT; and 12 LgDel embryos. Ø: genes for which
LgDel:Raldh2+/− levels are statistically indistinguishable from WT and Raldh2+/− levels; *: genes for which LgDel levels are significantly increased over both
Raldh2+/− and WT. Bottom left: scatterplots showing the ranges of individual hindbrain expression values for four ‘rescued’ genes in WT, LgDel (LD) and
LgDel:Raldh2+/− (LD:Ra). The minimum and maximum values in the WT and LgDel:Raldh2+/− are similar, and the minimum and maximum values for the LgDel
are consistently increased. Bottom right: Cyp26b1 patterns in the Raldh2+/− hindbrain are similar to WT (compare to WT panels in Figs 4 and 7); those in
LgDel:Raldh2+/− hindbrain resemble the Raldh2+/− and WT as well; in the LgDel, intensity increases in r6, r5, r4 and r3, the barely detectable expression in r2 is
more robust, and, in this case, apparently extends into r1. Right hand brackets show expansion of r5/6 in LgDel but not Raldh2+/− or LgDel:Raldh2+/− hindbrain;
left brackets show that r2-r4 are apparently compressed in the LgDel but not Raldh2+/− or LgDel:Raldh2+/− hindbrain.

in the WT and Raldh2+/− hindbrain (Fig. 8, middle panel). Hoxa1 in
the Raldh2+/− and LgDel:Raldh2+/− hindbrain remained at LgDel
levels (increased nearly twofold over WT; Fig. 8, middle, right).
Apparently, heterozygous Raldh2 deletion, and presumed RA
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signaling decrement (Maynard et al., 2013), restored WT expression
levels of most, but not all, RA-regulated, rhombomere-restricted
genes in LgDel:Raldh2+/− embryos. In contrast, there were no
differences between genotypes for any of these genes in the E9.5
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cervical and thoracic spinal cord (data not shown), indicating
specificity of localized hindbrain expression changes in response to
Raldh+/−. These changes are paralleled by diminished variability in
individual LgDel:Raldh2+/− gene expression toward WT ranges
(Fig. 8, lower left). Finally, increased Cyp26b1 labeling intensity in
LgDel r3-r6 as well as anterior expansion into r2 (see Figs 4, 7) was
not typically seen in the Raldh2+/− (9/11) or LgDel:Raldh2+/−
embryos (7/11). Apparently, restoration of WT expression levels and
patterns of RA-regulated, rhombomere-restricted genes accompanies
Raldh2+/− rescue of CN V phenotypes.
DISCUSSION

The LgDel 22q11DS mouse recapitulates several features of
perinatal dysphagia in 22q11DS patients: diminished weight gain,
food aspiration, and increased frequency of naso-sinus and
respiratory infections. As in 22q11 patients, palate and craniofacial
dysmorphogenesis accompany these changes, with varying
penetrance, in LgDel mice. Accordingly, the LgDel mouse models
yet another clinically significant 22q11DS phenotype: dysphagia –
and its impact on growth and health. These impairments are
paralleled by 22q11-dosage-dependent developmental pathology that
compromises rudimentary craniofacial structures and hindbrainderived CNs. Altered gene expression or patterning in the
embryonic hindbrain and CNg, followed by anomalous development
of CN V, IX and X, precede signs of dysphagia in LgDel mice.
Posterior CN IX and X phenotypes are primarily due to
heterozygous Tbx1 deletion, consistent with previous observations
in Tbx1−/− mice. Anterior LgDel CN V phenotypes, however, reflect
an altered balance of A-P patterning via RA-mediated changes in the
LgDel hindbrain. Thus, disrupted development of CNs that innervate
oro-facial structures required for feeding and swallowing prefigures
dysphagia-related phenotypes in the LgDel mouse. Similar early
developmental disruptions might contribute to perinatal dysphagia
in 22q11DS patients.
Dysphagia, growth, health and craniofacial morphogenesis
in LgDel mice

The LgDel mouse provides a model for developmental pathogenesis
of perinatal dysphagia in 22q11DS. The divergence in LgDel and
WT weight gain, similar to that in 22q11DS children (Tarquinio et
al., 2012), emerges 4 days after birth; therefore, it is unlikely to
reflect prenatal growth retardation. This deficit is likely caused by
diminished food intake via nursing and exacerbated by milkaspiration-related inflammation and infection. The presence of milk
protein in the nasal turbinates and lungs and accompanying
inflammation and infection by P7 indicates disrupted integrity of the
physical mechanism that directs food to the esophagus rather than
nasopharynx and trachea. Feeding difficulties can also be
exacerbated by additional chemosensory changes in the oro-facial
periphery. Altered olfactory capacity (Sobin et al., 2006) or
disrupted innervation of taste receptors or tongue muscles due to CN
IX, X, VII, XII anomalies might compromise appetite – as seen in
older children and adults with a variety of developmental disorders
whose food preferences are altered (Bennetto et al., 2007; Tavassoli
and Baron-Cohen, 2012). Cardiovascular or thymic anomalies might
also alter feeding and nutrition. Fourth pharyngeal arch artery
anomalies in LgDel mice (Merscher et al., 2001; Maynard et al.,
2013) might secondarily constrict the esophagus or trachea, as
reported in dogs with a high frequency of polymorphisms in 22q11
orthologs (Philipp et al., 2011) as well as 22q11DS patients (Phelan
et al., 2011). Congenital heart disease has been associated broadly
with feeding difficulties in infancy (Jadcherla et al., 2009), as has
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hypercalcemia due to thymic dysfunction during later life (Grieve
and Dixon, 1983; Balcombe, 1999). Interaction between these
diverse mechanisms might aggravate feeding and swallowing
difficulties. Our data indicates that they can be studied in LgDel
mice.
Disrupted CN development in 22q11DS

Diminished 22q11 gene dosage compromises initial CN innervation
of oro-facial and pharyngeal structures necessary for feeding and
swallowing by altering hindbrain A-P differentiation. Prior to
robust CN axon growth (E10.5 and later), anterior rhombomeres
appear compressed, CNg and motor roots are dysmorphic, and gene
expression in both the hindbrain and CNg changes. Gene
expression changes in the anterior hindbrain are extensive (see
below), suggesting that specification of motor as well as sensory
components of CN V and VII might be compromised. In addition,
neural crest cells from anterior rhombomeres contribute to
craniofacial targets of CN V, VII, IX and X involved in feeding and
swallowing, suggesting potentially negative synergy for oro-facial
functional development. The phenotypes we see are consistent with
dual disruption of CNs and targets by 22q11 deletion. In our initial
assessment of genes that regulate CN axon growth, we detected
expression changes in LgDel CNg V. Robo2, which is increased in
LgDel CNg V, is associated with phenotypes that parallel those in
the LgDel embryo (Ma and Tessier-Lavigne, 2007; Shiau et al.,
2008; Shiau and Bronner-Fraser, 2009; Kubilus and Linsenmayer,
2010). In contrast, there was a slight but significant decrease in
Robo2 in Tbx1+/− CNg V; however, CN V axon phenotypes were
not detected. Apparently, diminished Robo2 expression, in the
context of heterozygous Tbx1 mutation, does not disrupt CN V
development. It remains to be determined whether enhanced Robo2
in LgDel mice influences CN V development. Changes in CNg V
or other ganglia and nerves might reflect altered hindbrain neural
crest specification or altered peripheral target differentiation,
including epibranchial placodal contributions to the developing
ganglia.
Tbx1, CN development and dysphagia in 22q11DS

CN IX and X phenotypes in LgDel embryos were primarily due to
diminished dosage of Tbx1, a 22q11 candidate gene associated
with 22q11DS cardiovascular anomalies (reviewed by Scambler,
2010) that is not expressed in the developing hindbrain. In Tbx1
mutants, neural crest migration into the third, fourth and sixth
branchial arches is altered (Calmont et al., 2009), including that of
cells that will contribute to CN IX and X ganglia as well as cells
that provide a substrate for CN differentiation and axon growth.
CN IX and X ganglia fusions occur at similar frequency in Tbx1+/−
and LgDel embryos, suggesting that diminished Tbx1 dosage is
probably responsible for this anomaly. This Tbx1+/− phenotype is
consistent with an earlier report of CNg IX/X fusion in Tbx1−/−
null embryos (Vitelli et al., 2002). CN IX and X ganglia fusion
likely reflects disruptions of neural crest migration, pharyngeal
placode integrity, and subsequent differentiation in BA3, 4 and 6
(Raft et al., 2004; Arnold et al., 2006), perhaps exacerbated by
dysmorphogenesis of cardiac and visceral targets. These defects
alone, however, might not be sufficient to disrupt feeding and
swallowing. We did not see diminished P7 weight in Tbx1+/− pups
similar to that in LgDel pups. Furthermore, there are divergent
changes in gene expression between the two genotypes. Thus, our
results define a circumscribed role for diminished dosage of Tbx1
in a spectrum of phenotypes that together might account for
dysphagia in 22q11DS.
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22q11 deletion beyond Tbx1 disrupts anterior hindbrain
patterning

22q11 deletion, beyond heterozygous Tbx1 mutation, disrupts the
initial anterior hindbrain and subsequent CN patterning – especially
that of CN V. The changes appear focused on anterior-most
rhombomeres, r2-r3. The morphogenetic compression of the
hindbrain at E9.5 and E10.5 diminishes this territory and alters the
relative positions of CN V and VII. Deformations of the
neuroepithelium in this region could reflect altered cell proliferation,
enhanced cell death, or disrupted initial delamination and migration
of the neural crest from aberrant rhombomeres. Quantitative
expression changes target genes that define A-P hindbrain
boundaries or anterior rhombomeres themselves. Cyp26b1, which
shows the greatest expression level change, also expands anteriorly,
with anomalous increased expression in r2, r3 and r4. Apparently,
diminished 22q11 gene expression modifies the molecular and
cellular identities of rhombomeres that give rise to CN V. RA
regulates most of the genes selected for quantitative as well as
patterning analysis – including Cyp26b1 (Abu-Abed et al., 1998;
Okano et al., 2012). Changes in expression level or pattern are
consistent with increased anterior RA signaling in the LgDel
hindbrain. The anterior expansion of Cyp26b1 provides visual
reinforcement of the qPCR analysis, which showed enhanced
expression levels of a broader set of RA-regulated genes in the
microdissected E9.5 LgDel hindbrain. Together, these data solidly
support the hypothesis that diminished 22q11 gene dosage disrupts
development of CN V and, perhaps, CN VII as well, via increased
expression and/or anterior expansion of RA-regulated genes that
distinguish anterior versus posterior rhombomeres.
Selective rescue of LgDel CN V phenotypes by heterozygous
mutation of Raldh2 (Raldh2+/−), which lowers RA signaling in the
whole embryo by 20% (Maynard et al., 2013), establishes RAmediated disruption of CN development as a potential contributor
to dysphagia pathogenesis. Two clear conclusions emerge: first,
LgDel anterior CN differentiation is likely to be sensitive to RA
levels, whereas posterior CNs are not; second, Tbx1 disrupts

posterior CN IX/X gangliogenesis or axon growth independent of
RA signaling. In contrast, RA signaling is disrupted in the heart,
thymus and otic vesicle in Tbx1 mutants (Roberts et al., 2006;
Braunstein et al., 2009; Monks and Morrow, 2012), and Raldh2+/−
can rescue the thymic phenotype (Guris et al., 2006). The reduction
of RA levels by Raldh2+/− restored the expression of RA-regulated
genes in the LgDel hindbrain to WT levels, and the return of one of
these genes, Cyp26b1, to the WT pattern further defines a
mechanism by which 22q11 deletion, exclusive of Tbx1, disrupts
RA-regulated anterior hindbrain patterning, leading to altered CN V
development. This anterior disruption, together with Tbx1-mediated
posterior CN IX and X disruption, likely compromises the CN
innervation necessary for optimal feeding and swallowing. Thus,
dysphagia-associated phenotypes in LgDel pups reflect 22q11
contiguous genes that disrupt mechanisms of craniofacial and CN
development. Specific consequences for feeding and swallowing of
these aberrant mechanisms, and their amelioration by genetic or
pharmacological strategies involving RA or related signaling
pathways, remain to be determined.
MATERIALS AND METHODS
Animals

The George Washington (GW) University Animal Research Facility
maintained colonies of WT C57/BL6 (Charles River Laboratories), LgDel
(Merscher et al., 2001), Raldh2+/− (Mic et al., 2002) and Tbx1+/− (Jerome and
Papaioannou, 2001) mice. Mutant lines were backcrossed for at least ten
generations to the C57/BL6 background to generate breeding stock for these
experiments. The LgDel mutation (heterozygous deletion on mmchr. 16
from Idd to Hira) and Tbx1 mutations were transmitted paternally; Raldh2+/−
was transmitted maternally. All procedures were reviewed and approved by
the GW Institutional Animal Care and Use Committee (IACUC).
Animal measurements

Individual LgDel and WT littermate mouse pups from seven litters were
identified with unique labels at postnatal day 1 (P1), and weighed each
morning through P7, and then again at P14, P21, P28 and P30. All weights
were collected blind to genotype. These mice were sacrificed at day P30 by

Gene

F primer (5′-3′)

R primer (5′-3′)

Arvcf
Cdc45l
Cldn5
Comt
Dgcr1
Dgcr2
Dgcr6
Dgcr8
Gnb1l
Hira
Htf9c
Mrpl40
Prodh
Ranbp1
Septin5
Slc25a1
T10
Tbx1
Txnrd2
Ufd1l
Zdhhc8

GAGGGCCCGCCATCTTGAGC
CAGAGAAGCGCACACGGTTAGAAGAG
CTGGACCACAACATCGTGAC
CCTTCCTCCTGCTGGTGCGACACC
CGGCACGCGTGGCTCTACC
CATCCTCTCGCTGCTGCTTTTCAT
GAGACTGCGGCTGCAGAACGAACAC
TGCCCCATGAACAGTCTCCACCAC
CAGGGAAGGGCAGCGACGAGGTT
CTGCAAGGGCAGGACCACACTATTG
CTGCGCCCCCACTATGTCAAAAAG
GTGTGCTGCGCGGGCTCTG
AGCCGCCTGACCCTGGAGATGC
GACCCCCAGTTCGAGCCAATAGTTTC
GGTGCACCGCAAGTCCGTCAAG
CTGCGTGCGGCAAACTGTCC
CGCCCGTGGTAGAGGTGAACTTGT
GGGATTGCGACCCGGAGGACTG
GGAGCCCTGGAATATGGAATCACA
CAACTCAGCCGGCTCAACATTACC
CTGGCGCCCCGGTATGTGGTG

CAGGCCCCGAGGTTACTTGAGG
CCCATGTCTGCAAGGAACTCCTGGAG
GTACTTGACCGGGAAGCTGA
GCGAGGGCCTGTACTCCCGAATC
GGGGCTCTCGGATCCTTCTACTC
CCCCCTGGCGGTGCTTCTGTA
GGCCCTTCCCCTCCAAATCTGAAC
CCCCATAGGCCTACCCCATTACCA
CCCCGCAGCAAGCAAGCCATCAG
CCCCGGCTCCTGCTCTCACAAATG
CCAGGGTAGCAGGGCACGATTAGT
TCTCGAAGGGGAATAGGCTGGTA
CACGGCGGGACAGGTAAGGGAGTA
CATTTAGGAAGCGGATGGCGAGCAG
GGGCACCAGGCAGTCAGCTTTG
GGCCCTGCATCCTGGTCTTG
ATAGGTGGCACAGCGGACACACAC
GGCGGCGGCCGGGTACTTGTAG
GGCCGCCCCTCAGCAACATC
AGAACCAGAGAAGGCACGGAAGC
GGGGAGGGCGGGTAGGGAGGAC

Forward and reverse primers used for quantitative reverse-transcriptase polymerase chain reaction (qPCR) measurements of expression of a subset of mouse
orthologs of genes within the region of human chromosome 22 that is heterozygously deleted in 22q11DS as well as the LgDel mouse model of the disorder.
This subset was selected based upon extensive previous characterization of 22q11 gene expression in the embryo and the central nervous system (Maynard
et al., 2003; Meechan et al., 2009; Maynard et al., 2013).
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CO2 asphyxiation, and genotyped as described previously (Maynard et al.,
2003; Maynard et al., 2013). In addition, skulls were gross dissected and
digested in a solution of SNET (10 mM Tris pH 8.0, 0.1 M EDTA, 0.5%
SDS) and proteinase K (New England Biolabs) at 60°C for 3 days. Right
and left lower mandibles were cleaned and imaged in a standard orientation
on a Leica Wild M420 photomacroscope. Mandibular landmarks were
established (Richtsmeier et al., 2000) and landmark-to-landmark distances
were measured using ImageJ software (NIH 2012).
Histological analysis

After CO2 euthanasia, heads and lungs of P7 LgDel, WT and Tbx1+/− pups
were collected and fixed in 4% paraformaldehyde (PFA) at 4°C. The heads
were decalcified in 0.1 M EDTA in 0.1 M phosphate buffer. Heads and lungs
were cryoprotected and cryo-embedded, and 10 μm serial sections were
prepared and stained with hematoxylin and eosin (H&E) or periodic acidSchiff (PAS) reagents or immunolabeled with milk protein antibodies
(Biorbyt) at 1:1000 as well as anti-CD64 (neutrophil marker) at 1:200 (Santa
Cruz Biotechnology). For specificity, milk antibody was pre-adsorbed to an
acetone extract of E16 mouse embryos and adult mouse brain, liver and lung.
Alexa-Fluor-488 and -546 species-specific secondary antibodies were used for
detection. Sections were imaged using a Leica DM 6000B microscope.
RNA isolation, cDNA synthesis and qPCR

Hindbrains were dissected from E9.5 LgDel and WT littermates. Maxillary
[branchial arch (BA)1a] and mandibular/hyoid (BA1b/BA2) processes, as
well as CNg V, were dissected from E10.5 LgDel and WT littermates or
E10.5 Tbx1+/− and WT littermates. RNA was prepared as described
previously (Maynard et al., 2003). qPCR was performed using a Bio-Rad
CFX384 Real-Time PCR detection system. Gene-specific primers, when
possible, spanned genomic intron-exon boundaries and generated amplicons

between 250 and 350 bp, and were validated by melt-curve analysis (qPCR
Primers, Tables 1 and 2). Expression in LgDel or Tbx1+/− samples is
displayed as the fraction of expression in the WT littermate cohort. Mean
expression values between genotypes were compared using a t-test (P≤0.05).
Whole-mount immunohistochemistry

E10.5 embryos were fixed in 4% PFA at 4°C and dehydrated through a
graded methanol/PBS series. Embryos were incubated in 5:1 methanol:H2O2
for 30 minutes to quench endogenous peroxidases, rehydrated and incubated
for 1 hour in PBS with 0.2% BSA and 0.1% Triton X-100 (PBS-T), 10%
normal goat serum (NGS), 1% Boehringer Mannheim Blocking Reagent
(BMB) for 1 hour. For rhombomere analysis, rabbit polyclonal anti-Hoxb1
(r4-specific label; Covance, 1:400) and mouse monoclonal anti-En1
(r1/cerebellum/mesencephalon-specific label; Developmental Studies
Hybridoma Bank; 1:400) was used and, for CNs, mouse monoclonal anti165kDa neurofilament protein (2H3, Developmental Studies Hybridoma
Bank; 1:1000) was used. Embryos were incubated in primary antibodies at
4°C for 3 days. Embryos were then washed extensively in PBST and
incubated overnight in a 1:500 dilution of HRP-conjugated goat anti-rabbit
and HRP-conjugated goat anti-mouse antibodies (GE Healthcare Life
Sciences) for Hoxb1 and En1 or HRP-conjugated goat anti-mouse secondary
antibody (GE Healthcare Life Sciences) for neurofilament/2H3. Following
DAB/NiCl2 visualization of HRP, embryos were dehydrated, cleared with
benzyl alcohol:benzyl benzoate (BABB) and imaged using a Leica Wild
M420 photomacroscope.
In situ hybridization
A 503-bp fragment of Cyp26b1 (Accession number NM175475), chosen for
low homology to other Cyp26 family members, was subcloned into a
modified Bluescript vector, and digoxigenin-labeled probes (Roche) were

Gene

F primer (5′-3′)

R primer (5′-3′)

Bdnf
Cxcl12
Cyp26a1
Cyp26b1
Cyp26c1
E-cad
Egr2
EphrinB1
Gli1
Hoxa1
Hoxa2
Hoxa4
Hoxb1
L1cam
Lhx8
N-cad
ncam
Ngf
p75
Rara
Rarb
Robo1
Robo2
Robo3
Shh
Slit1
Slit2
Slit3
TrkA
TrkB
TrkC
VegFa

GGCTGACACTTTTGAGCACGTCATC
GACGCCAAGGTCGTCGCCGTG
CGAGCGCGGCCTCCTGGTCTAC
CGTGCGTGTGCTGCTAGGCTTCAG
GCCCAACGACCGGTGGCTGTTTAC
ACCGCGACCCTGCCTCTGAATC
GCCATCTCCCGCCACTCCGTTC
CCTCAGAGCCCGGCGAACATC
GACAGACTGCCGCTGGGATGGTTG
CCGTGCGCTCCCGCTGTTTACTC
GTCCATTGGGAGCCTGCTGTTGAG
CCGCCTATACCCGGCAGCAAGTC
CGACAGCTATGGAGCGGGTGGAGTC
GCTGCCTTGCCGACCCATTTAGAC
GGGGGCGGAGGAGGGGACAC
CGCTTCTGGCGGCCTTGCTTCAG
GCTCCCTGCCTCCAACCATCATCTG
CCCAGCCTCCACCCACCTCTTCAG
CGGCTCCTGGGTGCTGGGTGTTG
CCGGGACAAGAACTGCATCATCAA
AAACGACGACCCAGCAAGCCTCAC
TGGCAACCGCCTCCTGAAGACAC
GGGCCACTATGCTGCGGAACAAG
CACCGCTACCACCACGTTCCCAG
AGCGCGGGGACAGCTCACAAGTC
AGGCGGAAGGCAGCTGAGTTCAC
GTGCCCGGCCCAGTGCTCCTGTTC
TCTGGCGGCGGATGGCTTCAC
TGGCCGCCAGCAGGGTGTAGTTC
GCCCGCGATGTCCCAGCCACTGTG
GACGAGCGAGGACAATGGCTTCAC
ATCGCCAAGCCCGGAAGATTAG

GTGGCGCCGAACCCTCATAGAC
TTCGGGTCAATGCACACTTGTCTG
CTCCTCGATGCGCGCGTGTATAAG
GTCCAGGGCGTCCGAGTAGTCTTTG
GACGGCCTCATCCAGGTGCTCATAC
CTTGGCCGGTGATGCTGTAGAAAAC
TGATGACCGCCAAGGCCGTAGAC
GCCAGAGGGGGAAGGCACAAGAG
GCGGAGCGAGCTGGGATCTGTGTAG
GTGCGCACTGCGTTGGGTTGAC
ATCGCCGCGCTGCTGGATTTGAC
GGGCCGAGGCAGTGTTGGAAG
GCTGGCGCGTGGTGAAGTTTGTG
CAGGTGGCCAGCTTGCTCAGGTC
GCGGGGCCGAGGAGGAGCAG
GCATACACCGTGCCGTCCTCGTC
CGGCCTCGTCGTTTTTATCCACATTC
CGGCCAGCACTGTCACCTCCTTG
GGGTGGGCTCAGGACTCGTGTTCTC
GAGTCCGGTTCAGGGTCAGTCCAT
AGCTGGGGGACACGCTGGGACTG
GCTGCCCCAATGCCTGCAATG
GGGGATGGAGTAAGAGTGGCAGTG
TGCCCAGCGGCGCCCTCTTC
CCTCATCCCAGCCCTCGGTCACTC
CAGGGCCATGTCCGTGTTAGTTATG
CTCCCCTCTCGATGGTGCTGATTC
GACATGCATGGCGACTGGGGACTC
CGGGCCGAGGTCTCTGTCCAAGTC
CGGGTCCATGCCACTTCAGCCAG
GGCCGTGCCCAGGGCATTCTTAG
TTCGGCCTCTCTCAGACCACACTG

Forward and reverse primers used for qPCR measurements of expression of multiple genes related to patterning, morphogenesis, and differentiation of the
hindbrain, cranial nerves, cranial ganglia and craniofacial primordia.
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Table 2. Primers for signaling and patterning genes

made using T3 and T7 RNA polymerase (Promega). In situ hybridization on
whole E9.5 embryos was performed as described previously (Maynard et
al., 2002). Hybridized embryos were cleared in glycerol and photographed
after microdissection. Expression changes described in the text were based
upon independent assessments by two observers. All comparisons were done
in groups of embryos hybridized concurrently.
Assessment of phenotypes

Images of whole-mount labeled CNs and CNg were evaluated, blind to
genotype, by four independent observers. Scoring criteria were as follows:
for CN V, a score of 0 was assigned if there was a well-developed ganglion
with clear ophthalmic, maxillary and mandibular divisions and dense axon
fascicles growing toward the periphery. A score of 1 was assigned if the
trigeminal ganglion was smaller in overall size, or if outgrowing fibers were
short or sparse. For CN VII, a score of 0 was given if fibers of the main
branch bifurcated to grow toward both BA1 (the chorda tympani branch)
and BA2 (facial nerve); a score of 1 was assigned if there was no bifurcation
and the fibers grew toward only BA1 or BA2. For CN IX-X, a score of 0
was assigned if there was no contact between CN IX and X. A score of 1
was given if ectopic fibers were observed growing between CN IX and X
or if the ganglia were fused. These scores from four independent observers
were then tallied and the mean phenotypic scores determined. A mean score
of 0, 0.25 or 0.5 was reassigned a score of 0; a mean score of 0.75 or 1 was
given a score of 1. Fisher’s exact test was used to compare phenotypes in
groups with distinct genotypes.
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